Vol 2, No 4 (December 16, 2013): Chinese Clinical Oncology (Hepatocellular carcinoma - Guest Editor: Ghassan K. Abou-Alfa)

Preface

Hepatocellular carcinoma: what is happening everywhere?
Ghassan K. Abou-Alfa
Chinese Clinical Oncology  
2013;
2
(4)
:31
.

Review Articles

Viral hepatitis, non-alcoholic fatty liver disease and alcohol as risk factors for hepatocellular carcinoma
Maya Gambarin-Gelwan
Chinese Clinical Oncology  
2013;
2
(4)
:32
.
A review of hepatocellular carcinoma (HCC) staging systems
Somasundaram Subramaniam, Robin K. Kelley, Alan P. Venook
Chinese Clinical Oncology  
2013;
2
(4)
:33
.
Management of liver cirrhosis in patients with hepatocellular carcinoma
Bahaa Eldeen Senousy Ismail, Roniel Cabrera
Chinese Clinical Oncology  
2013;
2
(4)
:34
.
Hepatocellular carcinoma in the modern era: transplantation, ablation, open surgery or minimally invasive surgery?—A multidisciplinary personalized decision
Ioannis T. Konstantinidis, Yuman Fong
Chinese Clinical Oncology  
2013;
2
(4)
:35
.
Percutaneous therapies of hepatocellular carcinoma—an update
Julius Chapiro, Jean-François Henri Geschwind
Chinese Clinical Oncology  
2013;
2
(4)
:36
.
Systemic therapy for hepatocellular carcinoma
James J. Harding, Ghassan K. Abou-Alfa
Chinese Clinical Oncology  
2013;
2
(4)
:37
.
Features and treatment options of Chinese hepatocellular carcinoma
Qiong Wu, Shu-Kui Qin
Chinese Clinical Oncology  
2013;
2
(4)
:38
.
Status of hepatocellular carcinoma in South Korea
Seung Kew Yoon, Hoo Geun Chun
Chinese Clinical Oncology  
2013;
2
(4)
:39
.
Current status of hepatocellular carcinoma in Japan
Masafumi Ikeda, Shuichi Mitsunaga, Satoshi Shimizu, Izumi Ohno, Hideaki Takahashi, Hiroyuki Okuyama, Akiko Kuwahara, Takuji Okusaka
Chinese Clinical Oncology  
2013;
2
(4)
:40
.
Hepatocellular carcinoma in India
Gouri Shankar Bhattacharyya, K. Govind Babu, Hemant Malhotra, Anantbhushan A Ranade, Shaiqua Murshed, Debasis Datta
Chinese Clinical Oncology  
2013;
2
(4)
:41
.
Status of hepatocellular carcinoma in Gulf region
Kakil Ibrahim Rasul, Safaa H. Al-Azawi, Prem Chandra, Ghassan K. Abou-Alfa, Alexander Knuth
Chinese Clinical Oncology  
2013;
2
(4)
:42
.
Risk factors for developing hepatocellular carcinoma in Egypt
Ashraf Omar, Ghassan K. Abou-Alfa, Ahmed Khairy, Heba Omar
Chinese Clinical Oncology  
2013;
2
(4)
:43
.
Status of hepatocellular cancer in Europe
Alexa Childs, James O’Beirne, Tim Meyer
Chinese Clinical Oncology  
2013;
2
(4)
:44
.
Current status of hepatocellular carcinoma in the United States
Andrew X. Zhu
Chinese Clinical Oncology  
2013;
2
(4)
:45
.

Disclosure:

The focused issue “Hepatocellular carcinoma” was commissioned by the Editorial office, Chinese Clinical Oncology without any sponsorship or funding. Ghassan K. Abou-Alfa served as the unpaid Guest Editor for the focused issue.